Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas

Mary‐Ann El Sharouni; Tasnia Ahmed; Alexander H. R. Varey; Sjoerd G. Elias; Arjen J. Witkamp; V. Sigurdsson; Karijn P.M. Suijkerbuijk; P. J. van Diest; Richard A Scolyer; Carla H. van Gils; John F. Thompson; Willeke A.M. Blokx; Serigne Lo

doi:10.1200/jco.20.02446

Related publications

Letter2023

Development and validation of risk calculators for people with “thin” melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication

Mary‐Ann El Sharouni, Serigne Lo, Alexander H. R. Varey, Sjoerd G. Elias, Arjen J. Witkamp, V. Sigurdsson, Karijn P.M. Suijkerbuijk, P. J. van Diest, Carla H. van Gils, Willeke A.M. Blokx, Richard A Scolyer, John F. Thompson

Article2020

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

Serigne Lo, Jiawen Ma, Richard A Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey

Article2022

A tool to predict survival outcomes and guide adjuvant immunotherapy recommendations for patients with stage II melanoma.

Alexander H. R. Varey, Georgina V. Long, Richard A Scolyer, Jeffrey E. Gershenwald, Julie M. Simon, John F. Thompson, Serigne Lo

Article2024

Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas

Serigne Lo, Gabrielle Williams, Anne Ε. Cust, David W. Ollila, Alexander H. R. Varey, Sydney Ch’ng, Richard A Scolyer, John F. Thompson

Article2023

External validation and nomogram for risk factors of CNS metastasis in patients with clinically localized melanoma.

Merve Hasanov, Denái R. Milton, Serigne Lo, Jeffrey E. Gershenwald, Julie M. Simon, Georgina V. Long, Richard A Scolyer, Michael A. Davies